About UsPipelineInvestor RelationsContact

Arno Therapeutics, Inc.



Recent News

May 27, 2009
Arno Therapeutics Announces Three Poster Presentations at ASCO Annual Meeting more »

May 11, 2009
FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway more »

May 4, 2009
Arno Therapeutics to Deregister its Common Stock under the Exchange Act more »



Recent Events

The Ohio State University

Potential cancer therapies invented at Ohio State are licensed to drug development firm.
» Read

AACR
2008 AACR Annual Meeting, April 12-16, 2008, San Diego, CA
» Search abstracts